Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of CSF1 mRNA | decreases expression | 19933214
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of CSF1 mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of CSF1 mRNA | affects expression | 21346803
|
C091768 |
3'-methoxy-4'-nitroflavone |
3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA] | decreases reaction|increases expression | 19147701
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of CSF1 mRNA | affects expression | 17562736
|
C412373 |
AG 1879 |
AG 1879 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA] | decreases reaction|increases expression | 19147701
|
D013196 |
Dihydrotestosterone |
Dihydrotestosterone results in decreased expression of CSF1 mRNA | decreases expression | 17023530
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CSF1 mRNA | affects expression | 16483693
|
D003913 |
Dextroamphetamine |
Dextroamphetamine results in increased expression of CSF1 mRNA | increases expression | 12205029
|
D003913 |
Dextroamphetamine |
SOD1 inhibits the reaction [Dextroamphetamine results in increased expression of CSF1 mRNA] | decreases reaction|increases expression | 12205029
|
D001374 |
Azacitidine |
Azacitidine results in increased expression of CSF1 mRNA | increases expression | 17156202
|
D020122 |
tert-Butylhydroperoxide |
CSF1 protein results in decreased susceptibility to tert-Butylhydroperoxide | decreases response to substance | 16446085
|
C034456 |
CMF regimen |
CSF1 protein affects the susceptibility to CMF regimen | affects response to substance | 16618760
|
D003474 |
Curcumin |
Curcumin inhibits the reaction [CSF1 protein results in increased phosphorylation of CSF1R protein] | decreases reaction|increases phosphorylation | 15129424
|
D003520 |
Cyclophosphamide |
[Cyclophosphamide co-treated with Sizofiran] results in increased expression of CSF1 mRNA | affects cotreatment|increases expression | 10052129
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CSF1 mRNA | increases expression | 20106945
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CSF1 mRNA | affects cotreatment|decreases expression | 16054899
|
D002117 |
Calcitriol |
Calcitriol results in decreased expression of CSF1 mRNA | decreases expression | 16002434
|
D004128 |
Dimethylnitrosamine |
Dimethylnitrosamine results in increased expression of CSF1 protein | increases expression | 17719030
|
D004391 |
Dust |
Dust results in increased expression of CSF1 mRNA | increases expression | 17805423
|
C046770 |
EGTA acetoxymethyl ester |
EGTA acetoxymethyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA] | decreases reaction|increases expression | 19147701
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CSF1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSF1 mRNA | affects cotreatment|increases expression | 17942748
|
C109799 |
FK 706 |
FK 706 inhibits the reaction [IL1B protein results in increased expression of CSF1 protein] | decreases reaction|increases expression | 12676771
|
C109799 |
FK 706 |
FK 706 inhibits the reaction [TNF protein results in increased expression of CSF1 protein] | decreases reaction|increases expression | 12676771
|
D005472 |
Fluorouracil |
CSF1 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
D006632 |
Histamine |
Histamine results in decreased expression of CSF1 mRNA | decreases expression | 9657254
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CSF1 mRNA | affects cotreatment|decreases expression | 16054899
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of CSF1 mRNA | increases expression | 10223745
|
C104810 |
methyl arachidonylfluorophosphonate |
methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA] | decreases reaction|increases expression | 19147701
|
D009151 |
Mustard Gas |
Mustard Gas results in increased expression of CSF1 mRNA | increases expression | 15674844
|
C059514 |
resveratrol |
[resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CD14 mRNA | affects cotreatment|increases expression | 16267019
|
C059514 |
resveratrol |
[resveratrol co-treated with CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CSF1R mRNA | affects cotreatment|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in decreased expression of ITGAL mRNA] | affects cotreatment|decreases expression|decreases reaction | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased activity of ACP5 protein] | affects cotreatment|decreases reaction|increases activity | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of CTSK mRNA] | affects cotreatment|decreases reaction|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of NFATC1 mRNA] | affects cotreatment|decreases reaction|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of TNFRSF11A mRNA] | affects cotreatment|decreases reaction|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased expression of TNFRSF11A protein] | affects cotreatment|decreases reaction|increases expression | 16267019
|
C059514 |
resveratrol |
resveratrol inhibits the reaction [[CSF1 protein co-treated with TNFSF11 protein] results in increased localization of RELA protein] | affects cotreatment|decreases reaction|increases localization | 16267019
|
C059514 |
resveratrol |
resveratrol analog results in decreased expression of CSF1 mRNA | decreases expression | 15652768
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CSF1 mRNA | affects cotreatment|decreases expression | 16054899
|
D012643 |
Selenium |
Selenium results in increased expression of CSF1 mRNA | increases expression | 19244175
|
D012566 |
Sizofiran |
[Cyclophosphamide co-treated with Sizofiran] results in increased expression of CSF1 mRNA | affects cotreatment|increases expression | 10052129
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of CSF1 mRNA | decreases expression | 16014739
|
D013749 |
Tetrachlorodibenzodioxin |
3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA] | decreases reaction|increases expression | 19147701
|
D013749 |
Tetrachlorodibenzodioxin |
AG 1879 inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA] | decreases reaction|increases expression | 19147701
|
D013749 |
Tetrachlorodibenzodioxin |
AHR protein affects the reaction [Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA] | affects reaction|increases expression | 19147701
|
D013749 |
Tetrachlorodibenzodioxin |
EGTA acetoxymethyl ester inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA] | decreases reaction|increases expression | 19147701
|
D013749 |
Tetrachlorodibenzodioxin |
methyl arachidonylfluorophosphonate inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA] | decreases reaction|increases expression | 19147701
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of CSF1 mRNA | increases expression | 19147701
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CSF1 mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CSF1 mRNA | decreases expression | 19933214
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of CSF1 mRNA | increases expression | 16917069
|
D014028 |
Tobacco Smoke Pollution |
Tobacco Smoke Pollution results in decreased expression of CSF1 mRNA | decreases expression | 18087596
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.49 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.19 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.57 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.53 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
3.70 | 18653653 11850527 |
MESH:D000230 |
Adenocarcinoma |
|
Dimethylnitrosamine |
6.56 | 16033868 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
6.56 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
6.56 | 17638652 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Tobacco Smoke Pollution |
5.15 | 15814487 |
MESH:D000236 |
Adenoma |
|
Dimethylnitrosamine |
6.41 | 19555203 |
MESH:D000236 |
Adenoma |
|
resveratrol |
6.41 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.01 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.32 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.53 | 16712894 17306315 |
MESH:D019973 |
Alcohol-Related Disorders |
|
Curcumin |
4.71 | 17887948 |
MESH:D000544 |
Alzheimer Disease |
|
Curcumin |
6.23 | 15590663 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
6.23 | 16162502 16183991 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
6.23 | 19621015 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
7.63 | 16511603 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
7.63 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.47 | 10982225 |
MESH:D001161 |
Arteriosclerosis |
|
Cyclophosphamide |
8.98 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
8.98 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
11.01 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
11.01 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
11.01 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Curcumin |
4.75 | 16807698 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tobacco Smoke Pollution |
4.75 | 19898480 |
MESH:D001249 |
Asthma |
|
Histamine |
5.14 | 16387687 |
MESH:D001249 |
Asthma |
|
Mustard Gas |
5.14 | 10378619 |
MESH:D050197 |
Atherosclerosis |
|
Curcumin |
6.18 | 18704882 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
6.18 | 16873680 17967414 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.46 | 18445737 |
MESH:D001327 |
Autoimmune Diseases |
|
Curcumin |
4.13 | 19761891 |
MESH:D001768 |
Blister |
|
Mustard Gas |
4.79 | 19167455 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.72 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.42 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.53 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
Curcumin |
9.10 | 16770732 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
9.10 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Curcumin |
3.62 | 17596214 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 16618760 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
3.51 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
CMF regimen |
3.51 | 17145825 12006526 19115204 16234514 19151563 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Curcumin |
3.51 | 19250217 18462866 18593918 16243823 |
MESH:D001943 |
Breast Neoplasms |
|
Cyclophosphamide |
3.51 | 18234424 18323546 17388661 16978400 17020986 15136595 11325840 15093573 12006526 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.51 | 16110121 19217205 18357371 16595493 18608205 15136595 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
3.51 | 17651959 16393696 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.51 | 20435547 |
MESH:D001986 |
Bronchial Spasm |
|
Histamine |
5.44 | 18298128 |
MESH:D001989 |
Bronchiolitis Obliterans |
|
Mustard Gas |
4.79 | 15286001 |
MESH:D029481 |
Bronchitis, Chronic |
|
Mustard Gas |
4.60 | 17687719 10378619 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.29 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Curcumin |
17.58 | 18593918 |
MESH:D002277 |
Carcinoma |
|
Dimethylnitrosamine |
17.58 | 19555203 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
17.58 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
17.58 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
13.03 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
13.03 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
13.03 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cyclophosphamide |
13.03 | 19701751 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
13.03 | 16332177 17088986 17045692 16799960 18930000 17971768 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
13.03 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.03 | 17306315 15276417 16507464 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
Cyclophosphamide |
10.26 | 16152834 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
10.26 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Curcumin |
5.47 | 18414057 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Tobacco Smoke Pollution |
5.47 | 11212258 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Cyclophosphamide |
6.22 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.22 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
20.20 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Curcumin |
20.20 | 18462866 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Dimethylnitrosamine |
20.20 | 16033868 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
20.20 | 16757204 17066447 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
20.20 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
20.20 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tobacco Smoke Pollution |
20.20 | 11212258 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.16 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
3.22 | 15458977 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.36 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
9.70 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
9.70 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
9.70 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.85 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
6.88 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
6.88 | 17333356 16105132 15861022 11677210 17110522 17681005 16919318 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.95 | 12621046 15340226 16354765 8697196 15668235 |
MESH:D003092 |
Colitis |
|
Curcumin |
14.03 | 18200517 16804969 16782535 |
MESH:D003092 |
Colitis |
|
resveratrol |
14.03 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
14.03 | 17936198 |
MESH:D003103 |
Coloboma |
|
Curcumin |
4.22 | 18809619 |
MESH:D003110 |
Colonic Neoplasms |
|
Curcumin |
7.69 | 16340194 19359593 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
7.69 | 15824018 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
7.69 | 17287894 17725105 17172411 18772588 17018589 16510598 17016597 16340194 17169374 15001691 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
7.69 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Azacitidine |
3.39 | 19934284 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
3.39 | 17695437 16331619 20501625 16303861 18802399 17454858 16391804 15289873 16524972 18383874 18949393 17016601 14970324 18509181 17255274 16282729 18448328 15148649 17094418 17594712 18288408 17401013 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.39 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.75 | 17141729 14669216 |
MESH:D016510 |
Corneal Neovascularization |
|
Curcumin |
4.54 | 18497527 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.51 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
2.49 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.49 | 15322242 20055451 10048152 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
9.70 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
9.70 | 18551238 |
MESH:D003556 |
Cystitis |
|
Cyclophosphamide |
4.61 | 15643279 18295254 18093676 18433785 16413132 12161096 12388444 10700343 15276878 12913760 16614059 17010015 10498854 17979934 18372110 18483878 11948286 16989017 18710439 16651033 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.42 | 16733453 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.07 | 12438553 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
3.99 | 17446233 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Cyclophosphamide |
7.69 | 15331540 11751995 10990075 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
7.69 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Cyclophosphamide |
3.10 | 18772604 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Curcumin |
6.64 | 18403477 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
6.64 | 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
6.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Curcumin |
8.22 | 18204486 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
8.22 | 16286809 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.36 | 7237001 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
16.82 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
16.82 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
16.82 | 12958197 12540782 14986274 19739265 11287661 14725611 16081117 11529661 11834606 16781746 16227642 14550746 11461765 12153990 18071297 10663392 19416960 15968718 12705907 19923254 17522070 16109766 11421492 16393943 17906064 19420014 10915739 11743745 12392966 16485898 19164858 19085960 12594235 11739529 19370779 18713872 10774834 16177239 17562736 15619225 2444490 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Dimethylnitrosamine |
16.82 | 8172417 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
16.82 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
16.82 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
16.82 | 17522070 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.72 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.49 | 11462148 |
MESH:D004381 |
Duodenal Ulcer |
|
Curcumin |
3.70 | 17351913 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.11 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
18.22 | 19703484 |
MESH:D004487 |
Edema |
|
Mustard Gas |
18.22 | 9260866 11402378 11428631 11428647 |
MESH:D004487 |
Edema |
|
resveratrol |
18.22 | 8985016 |
MESH:D004487 |
Edema |
|
rosiglitazone |
18.22 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
18.22 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.53 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
13.39 | 15138306 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
13.39 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
13.39 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.71 | 10568697 9294722 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
4.03 | 17637181 15821434 15328337 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.49 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Cyclophosphamide |
8.41 | 11006010 |
MESH:D004802 |
Eosinophilia |
|
Histamine |
8.41 | 12689652 |
MESH:D004890 |
Erythema |
|
Mustard Gas |
4.79 | 9357497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Dimethylnitrosamine |
4.47 | 17016578 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.47 | 16337965 16481741 15173087 17638652 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.74 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Curcumin |
21.20 | 19297423 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
21.20 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
21.20 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
21.20 | 19196556 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
21.20 | 16917069 19224547 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.10 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.70 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Curcumin |
12.70 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
12.70 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
12.70 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.30 | 16983495 |
MESH:D005770 |
Gastrointestinal Neoplasms |
|
Curcumin |
4.33 | 18462866 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.31 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.85 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Curcumin |
3.24 | 17596214 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.72 | 16145905 |
MESH:D018316 |
Gliosarcoma |
|
Cyclophosphamide |
5.15 | 11389073 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.22 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Cyclophosphamide |
4.68 | 16376943 15172196 11014644 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Curcumin |
7.14 | 18829502 18462866 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.14 | 18337622 15162350 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.13 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
Selenium |
2.85 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.05 | 15720958 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.07 | 16366002 |
MESH:D006467 |
Hemophilia A |
|
Cyclophosphamide |
4.93 | 11918545 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.01 | 11000095 |
MESH:D006504 |
Hepatic Veno-Occlusive Disease |
|
Cyclophosphamide |
5.16 | 14986274 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.54 | 15340226 16120746 12621046 |
MESH:D015417 |
Hereditary Sensory and Motor Neuropathy |
|
Curcumin |
4.68 | 17701891 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
2.94 | 7520565 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.81 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
Cyclophosphamide |
6.61 | 17606976 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
6.61 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.67 | 16959395 18606429 8697196 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
6.93 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
6.93 | 12083418 |
MESH:D006937 |
Hypercholesterolemia |
|
Curcumin |
8.30 | 18704882 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
8.30 | 17188708 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.69 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.72 | 10903974 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
7.72 | 17042910 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.72 | 18670907 18850075 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.98 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.45 | 16945680 16569931 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.07 | 18306037 |
MESH:D007154 |
Immune System Diseases |
|
Cyclophosphamide |
4.96 | 16076520 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.29 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.12 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Cyclophosphamide |
9.86 | 7193160 16517039 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
9.86 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
9.86 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Curcumin |
25.19 | 16956363 18403477 17151092 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
25.19 | 11099482 8960868 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
25.19 | 17963957 12878042 17237260 9205823 17255318 |
MESH:D007249 |
Inflammation |
|
Mustard Gas |
25.19 | 9357497 11428620 16001271 9260866 11428647 17524151 11428631 8975870 11402378 |
MESH:D007249 |
Inflammation |
|
resveratrol |
25.19 | 16366677 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
25.19 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
25.19 | 12200463 12878042 |
MESH:D007249 |
Inflammation |
|
Tobacco Smoke Pollution |
25.19 | 18590791 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Curcumin |
3.06 | 18596194 18200517 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
9.83 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
9.83 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
3.56 | 16306350 |
MESH:D007414 |
Intestinal Neoplasms |
|
Curcumin |
3.90 | 10783313 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.29 | 17255318 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 16580747 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.07 | 18306037 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.07 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
8.75 | 15629191 12587719 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
8.75 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
8.75 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
3.56 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
15.32 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
15.32 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
15.32 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
15.32 | 16985049 |
MESH:D007889 |
Leiomyoma |
|
Curcumin |
4.23 | 18555241 |
MESH:D007938 |
Leukemia |
|
Azacitidine |
9.64 | 19148494 |
MESH:D007938 |
Leukemia |
|
Curcumin |
9.64 | 18462866 |
MESH:D007938 |
Leukemia |
|
Cyclophosphamide |
9.64 | 10602166 |
MESH:D015451 |
Leukemia, Lymphocytic, Chronic, B-Cell |
|
Cyclophosphamide |
3.34 | 17802794 17296974 17008537 17658394 18587576 18172266 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
Curcumin |
3.88 | 16106398 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
Cyclophosphamide |
3.82 | 10373061 |
MESH:D007951 |
Leukemia, Myeloid |
|
Azacitidine |
4.29 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Azacitidine |
2.94 | 18720364 17596541 |
MESH:D054429 |
Leukemia, Myelomonocytic, Juvenile |
|
Azacitidine |
4.85 | 19299654 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.34 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
Curcumin |
4.41 | 16106398 |
MESH:D007970 |
Leukopenia |
|
Cyclophosphamide |
10.54 | 10052129 11830472 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
10.54 | 15821434 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Curcumin |
8.06 | 17355460 18006644 18705752 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
8.06 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethylnitrosamine |
8.06 | 17201889 15138612 17348192 15723089 15864749 15366600 14568256 15298665 15383259 17666798 15942678 18371158 14726149 12918455 14709902 17196135 16627068 15339415 15369754 15504291 18672772 17719030 15479170 18095165 17465448 15744066 15067225 16270385 18567088 15763062 15591649 18210741 17203207 18629640 18637143 18237412 15571005 17036385 15577212 18364076 17198567 15099470 17724770 12925901 16009107 16042886 15798949 17881167 15161499 15492853 14643895 15842777 18239293 17432682 16603200 15793283 17534399 14659978 16169303 15733078 16544323 15086199 16570917 17640959 15081153 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
8.06 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
8.06 | 15980055 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
8.06 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.75 | 12969438 16611625 19014921 11587558 19784758 16610002 19460945 12587719 |
MESH:D008107 |
Liver Diseases |
|
Curcumin |
3.75 | 16956363 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
8.62 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Dimethylnitrosamine |
8.62 | 17457977 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
16.05 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Dimethylnitrosamine |
16.05 | 15890375 3113478 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
16.05 | 17045692 15113037 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
16.05 | 19073162 20405173 19812893 19321006 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
16.05 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
16.05 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
8.54 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Dimethylnitrosamine |
8.54 | 15603536 6150874 1848544 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
8.54 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Mustard Gas |
6.72 | 18161513 18702808 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
6.72 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
3.65 | 21114838 |
MESH:D008175 |
Lung Neoplasms |
|
Azacitidine |
14.36 | 21224363 |
MESH:D008175 |
Lung Neoplasms |
|
Curcumin |
14.36 | 18462866 16243823 19359593 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
14.36 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
Dimethylnitrosamine |
14.36 | 11884234 16061637 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
14.36 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Mustard Gas |
14.36 | 8781369 3148597 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
14.36 | 19931552 17306315 17077188 16712894 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
14.36 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tobacco Smoke Pollution |
14.36 | 12111688 16288123 3440675 11091918 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.42 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Curcumin |
7.06 | 18462866 |
MESH:D008223 |
Lymphoma |
|
Cyclophosphamide |
7.06 | 12854902 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Cyclophosphamide |
9.35 | 16675587 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
9.35 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Cyclophosphamide |
8.03 | 11911406 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
8.03 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Curcumin |
4.33 | 16173963 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.88 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
8.76 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
8.76 | 16827153 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
8.76 | 15318939 |
MESH:D008545 |
Melanoma |
|
Curcumin |
6.79 | 17885582 18462866 |
MESH:D008545 |
Melanoma |
|
Histamine |
6.79 | 17709802 |
MESH:D008545 |
Melanoma |
|
resveratrol |
6.79 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
6.79 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
9.64 | 19513568 |
MESH:D008546 |
Melanoma, Experimental |
|
Cyclophosphamide |
9.64 | 16388313 |
MESH:D008569 |
Memory Disorders |
|
Curcumin |
3.81 | 17263510 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.64 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.05 | 17112576 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.08 | 17261469 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.41 | 16801185 |
MESH:D009006 |
Monosomy |
|
Azacitidine |
5.71 | 19299654 |
MESH:D009041 |
Motion Sickness |
|
Dextroamphetamine |
5.15 | 1613127 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
8.02 | 16757204 18986760 |
MESH:D009062 |
Mouth Neoplasms |
|
Tobacco Smoke Pollution |
8.02 | 15006635 |
MESH:D009101 |
Multiple Myeloma |
|
Azacitidine |
15.20 | 18443271 19549372 |
MESH:D009101 |
Multiple Myeloma |
|
Curcumin |
15.20 | 19372569 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
15.20 | 16118317 15867202 15744524 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
15.20 | 17164350 16490592 16267019 14749477 17049120 17935668 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
Curcumin |
11.19 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
11.19 | 17962980 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Azacitidine |
7.16 | 17596541 18720364 17611569 19805378 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
7.16 | 9809623 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
2.87 | 17015251 17188708 17125593 16525036 16456233 16317513 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
8.05 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
8.05 | 12213967 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.39 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
9.12 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
9.12 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
Curcumin |
4.02 | 18495463 |
MESH:D009369 |
Neoplasms |
|
Cyclophosphamide |
7.33 | 18854779 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
7.33 | 16928823 18600527 18239605 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
7.33 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
8.04 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
8.04 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Curcumin |
4.16 | 12497104 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
4.41 | 9884423 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.07 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
2.98 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
2.87 | 14600291 |
MESH:D009423 |
Nervous System Neoplasms |
|
Curcumin |
5.26 | 18462866 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
2.90 | 12854658 |
MESH:D009447 |
Neuroblastoma |
|
Cyclophosphamide |
3.45 | 15176712 8761367 16115947 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
7.37 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
7.37 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cyclophosphamide |
4.52 | 12837982 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.06 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.19 | 16436463 |
MESH:D009503 |
Neutropenia |
|
Cyclophosphamide |
8.41 | 8291058 |
MESH:D009503 |
Neutropenia |
|
Mustard Gas |
8.41 | 7688884 16761898 |
MESH:D009765 |
Obesity |
|
Curcumin |
2.65 | 19297423 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
7.83 | 16049721 12819281 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
7.83 | 16049721 |
MESH:D009845 |
Oligospermia |
|
Cyclophosphamide |
4.34 | 16517039 |
MESH:D010001 |
Osteitis Deformans |
marker/mechanism |
|
| 20436471 |
MESH:D010024 |
Osteoporosis |
|
Curcumin |
3.24 | 18719352 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
3.92 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
Curcumin |
4.64 | 18462866 19020741 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.64 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
5.88 | 16870215 |
MESH:D010146 |
Pain |
|
Cyclophosphamide |
5.88 | 18093676 12161096 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Curcumin |
7.97 | 17440100 19401701 19196508 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cyclophosphamide |
7.97 | 11332152 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
7.97 | 19003803 16929163 16500647 15113037 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.35 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.87 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
5.06 | 11026799 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.51 | 15087411 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.19 | 11605937 12224865 |
MESH:D011041 |
Poisoning |
|
Mustard Gas |
3.46 | 15727166 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.21 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
2.92 | 12371664 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cyclophosphamide |
7.11 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
7.11 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
8.37 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.37 | 11399792 11896295 11222880 11118676 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
5.04 | 10903871 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.41 | 15572423 |
MESH:D011471 |
Prostatic Neoplasms |
|
Azacitidine |
2.04 | 18324645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.04 | 16644109 15754350 12479363 16289102 18247401 |
MESH:D011471 |
Prostatic Neoplasms |
|
Curcumin |
2.04 | 10851300 12497104 15129424 18156803 11398177 18226269 18769126 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cyclophosphamide |
2.04 | 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
2.04 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.04 | 16731767 17804756 15767336 17636462 17718901 17675339 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.04 | 16039940 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
8.30 | 16919318 15861022 |
MESH:D011537 |
Pruritus |
|
Mustard Gas |
8.30 | 18058305 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.10 | 16882103 |
MESH:D011656 |
Pulmonary Emphysema |
|
Curcumin |
4.21 | 19168576 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Cyclophosphamide |
5.51 | 16636934 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Mustard Gas |
5.51 | 17894541 17620002 10334151 17720292 17266442 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.70 | 16160472 18286688 18722050 15538739 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.21 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
3.09 | 15827377 17520802 16314181 16317513 17058453 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Curcumin |
8.18 | 18379247 10666014 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
8.18 | 18379247 11700416 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.49 | 10835634 |
MESH:D012135 |
Respiratory Sounds |
|
Tobacco Smoke Pollution |
4.27 | 18410779 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.49 | 18990726 |
MESH:D012220 |
Rhinitis |
|
Histamine |
4.66 | 12689652 |
MESH:D012509 |
Sarcoma |
|
Curcumin |
3.80 | 18462866 |
MESH:D012595 |
Scleroderma, Systemic |
|
Cyclophosphamide |
4.48 | 16636934 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
5.04 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.04 | 18551238 |
MESH:D018805 |
Sepsis |
|
Curcumin |
3.78 | 18389075 |
MESH:D012871 |
Skin Diseases |
|
Mustard Gas |
2.62 | 12880345 15451306 16961503 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
16.03 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
16.03 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
16.03 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
16.03 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tobacco Smoke Pollution |
16.03 | 18590791 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.57 | 16709447 |
OMIM:102530 |
SPERMATOGENIC FAILURE 6 |
|
Cyclophosphamide |
5.15 | 16517039 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.51 | 12854658 |
MESH:D013158 |
Splenic Diseases |
|
Dimethylnitrosamine |
4.89 | 12587719 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
3.95 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
Dimethylnitrosamine |
2.65 | 16033868 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.65 | 19015929 19084572 17498489 18396642 16951190 15786421 18567086 17522103 17172411 16424979 |
MESH:D013276 |
Stomach Ulcer |
|
Curcumin |
6.46 | 16631530 19188055 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
6.46 | 15138204 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.16 | 16321402 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Cyclophosphamide |
4.69 | 12837982 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.85 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.28 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.85 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.53 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.93 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.93 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
17.90 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
17.90 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Curcumin |
17.90 | 18593936 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cyclophosphamide |
17.90 | 14692829 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
17.90 | 16712894 16452187 11723127 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tobacco Smoke Pollution |
17.90 | 12846360 |
MESH:D014565 |
Urogenital Neoplasms |
|
Curcumin |
4.90 | 18462866 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
10.76 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
10.76 | 10091137 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
8.00 | 10982225 |
MESH:D014581 |
Urticaria |
|
Histamine |
8.00 | 18298128 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
14.08 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
14.08 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
14.08 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.34 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
8.34 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
10.52 | 1336536 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
10.52 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.06 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.22 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.21 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
3.94 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.87 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.07 | 17120751 |